Search for dissertations about: "thesis on dialysis"

Showing result 16 - 20 of 138 swedish dissertations containing the words thesis on dialysis.

  1. 16. Studies on treatment of renal anemia in patients on chronic hemodialysis

    Author : Bergur V. Stefánsson; Göteborgs universitet.; Gothenburg University.; [2011]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; hemodialysis; IV iron; oxidative stress; erythropoietin; hepcidin;

    Abstract : In patients with chronic kidney disease, treatment with erythropoiesis-stimulating agents (ESA) effectively corrects anemia. Most of these patients also need supplementation with regular iron injections to secure iron availability for proper erythropoiesis. READ MORE

  2. 17. Mechanisms of transendothelial and tissue transport in the peritoneum. Experimental studies on rat

    University dissertation from Bert-Inge Rosengren, Department of Nephrology, University Hospital of Lund, S-221 85 Lund

    Author : Bert-Inge Rosengren; [2003]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; nefrologi; Urologi; hyaluronan; interstitium; blood flow; rat; pore; inhibition; temperature; peritoneal dialysis; permeability; capillary; protein; passive; active; transport; transcytosis; vesicle; Urology; nephrology; small solute;

    Abstract : In the present thesis, the quantitative role of active transport (transcytosis) in bulk transvascular protein movement in vivo was evaluated. Using chemical transcytosis inhibition (N-ethylmaleimide (NEM) and filipin), we were able to show that NEM actually increases endothelial permeability to macromolecules, probably as a result of unspecific toxic action on endothelial cells. READ MORE

  3. 18. Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors

    University dissertation from Umeå : Umeå universitet

    Author : Dana Mahmood; Bernd Stegmayr; Gunilla Olivecrona; Per Ola Attman; [2012]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Haemodialysis; lipoprotein lipase; ANGPTL3; ANGPTL4; citrate dialysate; dialyzer.; medicin; Medicine;

    Abstract : Cardiovascular disease is a major cause of mortality and morbidity in patients on chronic haemodialysis (HD). One main contributing factor is renal dyslipidaemia, characterized by an impaired catabolism of triglyceride (TG)-rich lipoproteins with accumulation of atherogenic remnant particles. READ MORE

  4. 19. Analysis of Transvascular Transport Phenomena in the glomerular and peritoneal microcirculation

    University dissertation from Lund University: Faculty of Medicine

    Author : CARL ÖBERG; [2016]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Peritoneal dialysis; glomerular filtration barrier; pore model; automated peritoneal dialysis APD ; three-pore model;

    Abstract : The current work is devoted entirely to the study of passive transport phenomena, or more specifically, the more simple diffusion, electric migration and filtration of solute matter and water over glomerular and peritoneal capillary walls. The driving forces behind such trans-capillary transport phenomena have long been assumed to be simple gradients of concentration, hydrostatic pressure and electric potential. READ MORE

  5. 20. Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin

    University dissertation from Umeå : Umeå universitet

    Author : Benny Holmberg; Bernd G Stegmayr; Christer Andersson; Peter M Nilsson; [2013]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Atorvastatin; cholesterol; chronic kidney disease; haemodialysis; cholesterol; lipids; peritoneal dialysis; risk factors; statins; inter dialysis weight gain;

    Abstract : Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine clearance</30 ml/min) and to influence risk factors. READ MORE